Obesity Clinical Trial
Official title:
The Impact of Higher Dairy and Dietary Protein on the "Quality" of Hypoenergetic diet-and Exercise-induced Weight Loss in Pre-menopausal, Overweight and Obese Young Women
Diets all share the same principle: eat less energy than you need. This results in weight
loss. However, the weight loss is usually a combination of a loss of body fat and muscle
mass. Additionally, one's bones may begin to weaken, albeit very slowly, while on a diet,
which could have serious long-term consequences. Thus, the investigators believe that the
goal of any weight loss strategy should be to lose body fat and spare muscle. The
investigators reasoning is two-fold. 1) Fat is not only stored under the skin, but also in
and around the internal organs. When this occurs, the organ itself may not function
properly. Losing fat mass is a very good thing from a health standpoint, since fat is not
just a storage site for extra energy. Scientists have now shown that 'extra' body fat itself
can actually secrete substances and when these substances get into your blood, they cause
many problems and may even contribute to the development of diabetes. 2) Sparing muscle as
an individual loses weight is very important. Muscle is a very 'metabolically active' tissue
and is, by analogy, like the body's furnace. Muscle burns fuel from the food individuals eat
and also from stored fuels, like fat. Hence, it's easy to see why you don't want to lose
muscle because you'd be losing one of your body's best fat burners. More importantly, muscle
is also a big storage site and furnace for blood sugar. In people with diabetes (elevated
blood sugar), a big part of the problem is with their muscles - they simply do not take up
and store or burn enough sugar. For these reasons, your goal should be to lose fat and
preserve muscle while dieting.
There are many different diets to choose from (e.g. high protein, low carbohydrate, high
fat, high fiber, etc.). A diet that has been shown to be quite successful, however, is one
that is higher in protein (but not excessive). Thus, in this study, the investigators are
proposing to test whether a higher protein (with dairy) and calcium diet promotes body fat
loss and muscle mass retention. The investigators believe that a diet higher in protein
(with an emphasis on dairy), but still within accepted healthy ranges, with higher dietary
calcium may result in greater loss of body fat and retention of muscle than a diet with a
conventional amount of protein and adequate calcium or a conventional amount of protein with
little calcium (i.e. low dairy). Based on previous research, the investigators think that
people with low calcium intakes to begin with would stand to benefit the most. There is also
a good reason to think that the high protein/high calcium diet may result in greater
reductions in blood cholesterol and blood sugar, both of which would reduce a person's risk
for heart disease and diabetes.
The investigators will test this diet in premenopausal women who are overweight or obese.
The investigators believe that this group is a good one to target for several reasons.
First, women of this age who are overweight or obese are, if they continue to carry this
excess weight, are at serious risk for developing chronic diseases such as heart disease,
diabetes, and possibly cancer at an early age. Second, these women will often begin to
gradually consume less dairy because many perceive dairy foods as fattening. Thus, if the
investigators proposals are correct the investigators will hopefully be able to equip health
professionals with a tried and tested, palatable, dietary strategy in a population segment
who, because of their age, would benefit greatly were their disease risk to be reduced.
Overweight to obese female subjects, who are habitually low dairy consumers and between the
ages of 19-45 years will be recruited from the McMaster University student and staff
population and from the surrounding Hamilton area. At study entry, all subjects will be
asked to complete a standard screening questionnaire to document their medical history,
current medication use, physical activity level, smoking habits, and alcohol consumption.
Subjects will also complete a calcium food frequency questionnaire. Before randomization and
study commencement, baseline measures will be done. These include: anthropometrics, fasting
blood samples, fasting urine sample, resting energy expenditure measures (REE), muscle and
adipose biopsies, cardiovascular measures (blood pressure, heart rate, blood vessel
stiffness and arterial elasticity) body composition (dual-energy x-ray absorptiometry
[DXA]), and a 7-day baseline food record analysis. Also, subjects' strength and fitness will
be assessed (1 repetition maximum (RM) and submaximal Astrand Test evaluations). During the
study, fasting blood samples will also be taken at weeks 4, 8, 12 and 16, DXA will also be
done at weeks 8 and 16, validated Body Image questionnaires will be filled out again t weeks
8 and 16, and body weight will be recorded every week. All other measures will be repeated
after 16 weeks (1RM, Astrand Test, biopsies, cardiovascular measures, REE). Magnetic
Resonance Imaging (MRI) will be carried out on a smaller portion of subjects on a voluntary
basis at weeks 0 and 16. Apon completion of the baseline testing, subjects will be randomly
assigned to one of the three intervention groups.
Part of the intervention will be in the form of 2 daily chocolate drinks (a post-exercise
drink plus one extra drink per day). Drink composition will differ depending on which group
subjects are randomized to. Drinks will be made to look and taste similar. In terms of the
daily diets, the DairyPro (middle/second) group will employ the same macronutrient
distribution as the Control (first) group but half the protein will be derived from dairy
sources, with subjects being asked to consume, on top of their supplemental chocolate drink,
2 yogurts (100 g each). In the control group, protein will be derived from sources other
than dairy. In the HiDairyPro (third) group, dietary protein will be manipulated so as to
comprise twice as much dietary energy versus the other two groups (i.e., 30% of energy
intake versus 15%). Protein (half of their daily requirement) will be derived from dairy
protein by asking subjects to consume, on top of their supplemental chocolate drink, 1
serving (250 ml) of 1% regular milk, 4 yogurts (100 g each) and 2 pieces of cheese (21 g
each).
Overview of supplemental drink composition and diet composition by group:
1. Control (Con) - a group consuming twice daily drinks containing no dairy protein or
calcium. Daily protein (15% total kcals) should be from non-dairy sources (i.e. meat,
egg, fish, chicken, lentils, beans, wheat gluten).
2. Dairy Protein Group (DairyPro) - a group consuming twice daily drinks containing 1%
chocolate milk and at least half of their daily protein (15% total kcals) intake from
dairy sources.
3. High Dairy Protein Group (HiDairyPro) - a group consuming twice daily drinks containing
1% artificially sweetened chocolate milk along with a diet formulated to contain 30%
(as opposed to only 15% in the Con and DairyPro groups) of their dietary energy from
protein with at least half of that coming from dairy protein.
Subjects will meet with a study dietitian/nutritionist at the beginning and biweekly
throughout the 16 weeks, and be provided with individual dietary counseling to reduce daily
calories by 500 kcal/d. Subjects will be provided with template diet records, nutrition
information sheets and macronutrient specific exchange lists to help with dietary compliance
and to promote healthy food choices. The weight-reducing diets will have macronutrient and
micronutrient profiles that are in accordance with the dietary regulations set forth by
Canada's Food Guide and the dietary reference intakes (DRIs). The macronutrient profile of
the 2 moderate protein groups (control and DairyPro) will be 15:30:55 (PRO:Fat:CHO), whereas
the subjects in the High dairy protein group (HiDairyPro) will consume a profile of 30:30:40
(15% substitution of carbohydrate for protein). Subjects will consume all other food (aside
from their designated drinks) in any manner they choose in accordance with the macronutrient
profile of their respective randomization allocations. Adherence to the prescribed diet will
be via collection of assigned biweekly food records, frequent contact with subjects, and
regular dietary counseling sessions.
In addition, all subjects will be given a custom exercise prescription consisting of
supervised resistance exercise and aerobic exercise. Intensity and duration of all exercise
sessions will be monitored and energy expenditure quantified using portable, validated units
that integrate accelerometry, heat flux and skin temperature. Exercise will take place in a
supervised setting at McMaster University. Subjects will perform exercise 7d/wk and will
exercise supervised 5d/wk (Mon - Fri). Resistance training sessions will take place 2x/week.
During these sessions, subjects will engage in a circuit weightlifting routine using guided
motion machines.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |